[1]
“CONTINUOUS GLUCOSE MONITORING VERSUS ROUTINE SELF-MONITORING ON TREATMENT ADHERENCE IN TYPE 2 DIABETES PATIENT”, AJSI, vol. 2, no. 2, pp. 9–18, Jul. 2025, doi: 10.67129/c0cqx225.